Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ian T Clark

Director at Guardant Health, Inc. (GH); Director at Olema Pharmaceuticals, Inc. (OLMA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13.9M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 5SEC GHGuardant Health, Inc. Sell 9,0888,067 held (−53%) $158.98 $1.4M +5.3%
Aug 5SEC GHGuardant Health, Inc. Sell 5,0922,975 held (−63%) $158.80 $809K +5.5%
May 22SEC GHGuardant Health, Inc. Sell 6,8762,975 held (−70%) $106.90 $735K +56.7%
Dec 23SEC OLMAOlema Pharmaceuticals, Inc. Sell 29,904234,896 held (−11%) $28.83 $862K -72.9%
Dec 23SEC OLMAOlema Pharmaceuticals, Inc. Sell 193,05641,840 held (−82%) $29.71 $5.7M -73.7%
Dec 23SEC OLMAOlema Pharmaceuticals, Inc. Sell 41,840 $30.48 $1.3M -74.3%
Dec 8SEC GHGuardant Health, Inc. Sell 8,15630,306 held (−21%) $106.67 $870K +57.0%
Dec 8SEC GHGuardant Health, Inc. Sell 17,05513,251 held (−56%) $107.27 $1.8M +56.1%
Dec 8SEC GHGuardant Health, Inc. Sell 3,4009,851 held (−26%) $108.05 $367K +55.0%
  • Sell

    Director Ian T Clark sold $1.4M of GH at $158.98 — cuts the stake by 53%.

  • Sell

    Director Ian T Clark sold $809K of GH at $158.80 — cuts the stake by 63%.

  • Sell

    Director Ian T Clark sold $735K of GH at $106.90 — cuts the stake by 70%.

  • Sell

    Director Ian T Clark sold $5.7M of OLMA at $29.71 — cuts the stake by 82%.

  • Sell

    Director Ian T Clark sold $1.8M of GH at $107.27 — cuts the stake by 56%.

  • Sell

    Director Ian T Clark sold $367K of GH at $108.05 — cuts the stake by 26%.